Analyst Ratings For AtriCure (NASDAQ:ATRC)
Today, Canaccord Genuity reiterated its Buy rating on AtriCure (NASDAQ:ATRC) with a price target of $28.00.
There are 1 hold rating, 6 buy ratings on the stock.
The current consensus rating on AtriCure (NASDAQ:ATRC) is Buy (Score: 2.86) with a consensus target price of $25.83 per share, a potential 14.81% upside.
Some recent analyst ratings include
- 10/9/2017-Canaccord Genuity Reiterated Rating of Buy.
- 7/30/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/28/2017-Needham & Company LLC Reiterated Rating of Buy .
- 6/16/2017-Leerink Swann Reiterated Rating of Outperform.
- 5/30/2017-Piper Jaffray Companies Reiterated Rating of Overweight .
- 3/20/2017-Northland Securities Reiterated Rating of Buy.
- 3/6/2017-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating.
Recent Insider Trading Activity For AtriCure (NASDAQ:ATRC)
AtriCure (NASDAQ:ATRC) has insider ownership of 10.00% and institutional ownership of 82.11%.
- On 8/22/2017 Elizabeth D Krell, Director, sold 10,000 with an average share price of $22.40 per share and the total transaction amounting to $224,000.00. View SEC Filing
- On 5/17/2017 Elizabeth D Krell, Director, sold 10,000 with an average share price of $21.44 per share and the total transaction amounting to $214,400.00. View SEC Filing
- On 3/17/2017 Andrew L Lux, SVP, sold 20,000 with an average share price of $18.85 per share and the total transaction amounting to $377,000.00. View SEC Filing
- On 11/15/2016 Elizabeth D Krell, Director, sold 10,000 with an average share price of $19.73 per share and the total transaction amounting to $197,300.00. View SEC Filing
- On 9/13/2016 Elizabeth D Krell, Director, sold 6,000 with an average share price of $15.93 per share and the total transaction amounting to $95,580.00. View SEC Filing
- On 8/17/2016 Elizabeth D Krell, Director, sold 5,000 with an average share price of $15.20 per share and the total transaction amounting to $76,000.00. View SEC Filing
- On 3/8/2016 Elizabeth D Krell, Director, sold 10,000 with an average share price of $16.91 per share and the total transaction amounting to $169,100.00. View SEC Filing
Recent Trading Activity for AtriCure (NASDAQ:ATRC)
Shares of AtriCure closed the previous trading session at with shares trading hands.